Related Experiment Video
Updated: Mar 18, 2026
07:41
A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
Published on: March 8, 2022
3.0K
Serpine2, a potential novel target for combating melanoma metastasis
1Department of Dermatology, Tongren Hospital, Shanghai Jiao Tong University School of Medicine 1111 Xianxia Road, Shanghai 200336, China.
American Journal of Translational Research
|June 28, 2016
Summary
Serpin Peptidase Inhibitor 2 (Serpine2) drives melanoma cell metastasis. Inhibiting Serpine2 significantly reduced tumor spread in vivo, offering a potential new therapeutic target for advanced melanoma.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Melanoma treatment is limited for metastatic stages.
- Molecular mechanisms of melanoma metastasis are not fully understood.
- Identifying metastasis drivers is crucial for new therapies.
Purpose of the Study:
- To investigate the role of Serpin Peptidase Inhibitor 2 (Serpine2) in melanoma metastasis.
- To elucidate the molecular pathways involved in Serpine2-mediated melanoma progression.
Main Methods:
- Gene silencing and over-expression of Serpine2 in melanoma cells in vitro.
- In vivo studies to assess the impact of Serpine2 on melanoma metastasis.
- Analysis of the glycogen synthesis kinase 3β (GSK-3β) signaling pathway.
Main Results:
- Serpine2 expression is critical for melanoma cell migration in vitro.
- Down-regulation of Serpine2 significantly inhibited melanoma metastasis in vivo.
- Serpine2 promotes melanoma metastasis via the GSK-3β signaling pathway.
Conclusions:
- Serpine2 is a novel regulator of melanoma metastasis.
- Targeting Serpine2 may offer a new therapeutic strategy for melanoma.
- The GSK-3β pathway is implicated in Serpine2-driven melanoma progression.
